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A B S T R A C T
Objectives: To determine the eﬀect of Adaptive Statistical Iterative Reconstruction (ASIR) on perfusion CT (pCT)
parameter quantitation and image quality in primary colorectal cancer.
Methods: Prospective observational study. Following institutional review board approval and informed consent,
32 patients with colorectal adenocarcinoma underwent pCT (100 kV, 150 mA, 120 s acquisition, axial mode).
Tumour regional blood ﬂow (BF), blood volume (BV), mean transit time (MTT) and permeability surface area
product (PS) were determined using identical regions-of-interests for ASIR percentages of 0%, 20%, 40%, 60%,
80% and 100%. Image noise, contrast-to-noise ratio (CNR) and pCT parameters were assessed across ASIR
percentages. Coeﬃcients of variation (CV), repeated measures analysis of variance (rANOVA) and Spearman’
rank order correlation were performed with statistical signiﬁcance at 5%.
Results: With increasing ASIR percentages, image noise decreased by 33% while CNR increased by 61%; peak
tumour CNR was greater than 1.5 with 60% ASIR and above. Mean BF, BV, MTT and PS diﬀered by less than
1.8%, 2.9%, 2.5% and 2.6% across ASIR percentages. CV were 4.9%, 4.2%, 3.3% and 7.9%; rANOVA P values:
0.85, 0.62, 0.02 and 0.81 respectively.
Conclusions: ASIR improves image noise and CNR without altering pCT parameters substantially.
1. Introduction
Perfusion computed tomography (pCT) techniques enable in-vivo
tumour vascularisation to be evaluated in clinical practice [1]. Regional
blood ﬂow (BF), blood volume (BV) and permeability surface area product
(PS), derived from the temporal changes in vascular and tissue attenuation
following an intravenous bolus injection of standard CT iodinated contrast
agent, act as surrogate measures of tumour angiogenesis and perfusion-
related hypoxia across diﬀerent tumour types [2–6]. Perfusion CT is
clinically relevant in colorectal cancer. Staging blood ﬂow is lower in
patients with nodal metastases [7], those who subsequently present with
metastases despite curative surgery [8], and those who have a poorer
overall survival [7]. This is thought to reﬂect perfusion-related hypoxia,
supporting the use of pCT in oncologic clinical trials as a prognostic and
response biomarker [1].
In recent years, the clinical emphasis on dose-reduction has led all
major CT manufacturers to implement hybrid iterative image reconstruc-
tion techniques instead of traditional analytical ﬁltered back projection
(FBP) reconstruction, in order to compensate for the increase in image
noise with low-dose CT acquisitions. These hybrid algorithms combine
analytical and iterative methods in a number of ways. Adaptive statistical
iterative reconstruction (ASIR) uses the image information obtained from
FBP as an initial building block for further iterative reconstruction to
improve image characteristics, including noise. This has enabled dose
reductions between 32% and 65% in phantom studies without substan-
tially aﬀecting image quality [9,10] subsequently conﬁrmed by clinical
studies, both paediatric [11–13] and adult [14–21]. The impact of
iterative reconstruction techniques on quantitative pCT analysis has
not been investigated and is clinically relevant, given their widespread
use. The aim of this prospective study was to assess the eﬀect of ASIR on
image quality and pCT quantitation in primary colorectal cancer.
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2. Materials and methods
2.1. Patients
Institutional review board approval and written informed consent
were obtained prospectively for this single-centre observational study, as
part of a multicentre NIHR HTA funded study aimed at evaluating a
prognostic model of conventional predictive variables and novel vari-
ables derived from pCT to improve the prediction of metastatic disease in
primary colorectal cancer. Inclusion criteria were adult patients with a
diagnosis of colorectal cancer. Exclusion criteria were standard contra-
indications to iodinated contrast agent (including previous iodinated
contrast agent reaction, impaired renal function, lack of intravenous
access) and no visible tumour on the planning CT acquisition. Thirty-four
patients agreed to participate from January 2012 to July 2014. In two
patients technical errors precluded analysis, leaving 32 patients (27 men,
5 women) in this study group. Mean (SD) patient age was 71.3 years ±
10.5 (men: 71.1 years ± 10.6; range, 38–91 years; women:
72.2 ± 11.5; range, 54–84 years). Mean (SD) patient size, measured
in the axial plane immediately cranially to the iliac crest, was
24.28 ± 3.23 cm (latero-lateral; range, 17.89-31.06 cm) × 35.67 ±
2.73 cm (antero-posterior; range, 30.45–40.99). Tumours had a mean
diameter of 4.5 cm ± 2.1 (range, 2.0–10.1 cm) and were located as
follows: cecum [5], ascending colon [4], descending colon [1], sigmoid
colon [7], rectum [15]. Radiological tumour (T) and nodal (N) staging,
evaluated on CT images only and based on the UICC TNM Classiﬁcation
of Malignant Tumours, Seventh Edition, was as follows: T2 [12], T3 [17],
T4 [3], N0 [16], N1 [11], N2 [5].
2.2. CT perfusion technique
To minimise bowel peristaltic movement, 20 mg of the spasmolytic
agent hyoscine butylbromide (Buscopan; Boehringer Ingelheim,
Ingelheim am Rhein, Germany) were administered intravenously prior
to data acquisition unless contraindicated. Perfusion CT was performed
on a Discovery 750 HD multi-detector CT(GE Healthcare, Waukesha,
USA). An initial low dose abdominal or pelvic planning sequence was
performed, without intravenous contrast material, to locate the color-
ectal tumour (100 kV, 50 mA with smart mA, 5-mm slice collimation,
50-cm scan ﬁeld of view, 512 × 512 mm matrix). The tumour was
identiﬁed by the supervising radiologist and the acquisition coordinates
were used to plan the subsequent dynamic pCT acquisition, which was
centred at mid-tumour level. 50 mL of 370 mg/mL iodinated contrast
agent (Niopam, Bracco S.p.A, Milan, Italy) were injected intravenously
through a pump injector (Medrad Stellant dual syringe, Bayer
Healthcare, Leverkusen, Germany) at a rate of 5 mL/sec, followed by
a 50 mL saline chaser injected at the same rate. The pCT acquisition
consisted of 8 contiguous 5 mm slices (4 cm z-axis coverage), obtained
at 1.5 s intervals for 45 s (perfusion phase) and at 15 s intervals for a
further 75 s (interstitial phase), giving a total number of 35 acquisition
time points with the following acquisition parameters: 100 kV; 150 mA
without tube current modulation; axial mode; 0.5 s rotation time; 50 cm
scan ﬁeld of view; 512 × 512 mm matrix; B30 soft reconstruction
kernel; 10 s delay after IV contrast agent injection; breath intermit-
tently held in expiration during the perfusion and interstitial phase to
minimise respiratory excursion. Mean CTDIVol and DLP were
137.8 ± 15.3 mGy and 551.0 ± 61.2 mGy cm respectively.
2.3. Image analysis
All pCT acquisitions were reconstructed at 6 diﬀerent ASIR percen-
tages: 0% ASIR (equivalent to FBP) and with increasing percentages of
20%, 40%, 60%, 80% and 100% ASIR, resulting in 6 separate pCT
datasets per patient (Fig. 1). With the aim of eliminating interobserver
variability, image data were analysed by two readers in consensus [with
1 year (SV) and>15 years’ (VG) CT perfusion experience respectively]
on a workstation (Advantage Windows 4.6; GE Healthcare, Chicago,
USA) using commercial perfusion software (Perfusion 4; GE Healthcare,
Chicago, USA). A processing threshold of−50 to 150 HU was chosen to
optimise soft tissue visualisation. No motion correction algorithm was
applied. An arterial input was deﬁned by placing a 1 cm2 circular
region-of-interest (ROI) within the best visualised artery (aorta, iliac, or
femoral) to derive the arterial time-enhancement curve. Parametric
maps (BF, BV, MTT and PS) were generated, with each pixel represent-
ing a parameter value, based on the maximum slope method algorithm
and a modiﬁed Johnson and Wilson distributed parameter model (GE
Healthcare, Chicago, USA). A tumour ROI was outlined on each axial
image where tumour was visualised, ensuring that the entire tumour
was encompassed within the ROIs; luminal gas was excluded where
present.
The analysis of 0% ASIR images was conducted ﬁrst; the delineated
ROIs were saved by the software to allow these to be propagated onto
subsequent datasets with diﬀerent ASIR percentages (20–100%), thus
avoiding any measurement variation related to ROI placement. The
mean values for each of the four tumour pCT parameters – BF, BV, MTT
and PS – were recorded. The entire process was repeated in the same
manner for each patient and for all the subsequent ASIR datasets- 20%,
40%, 60%, 80% and 100% – using the exact same ROI.
2.4. Assessment of image quality
Image noise and contrast to noise ratio (CNR) were calculated from
the grey-scale images. For each patient and ASIR percentage, tumour
baseline density and peak enhancement were recorded from the tissue
time-density curve on a single gray-scale image; a ﬁxed circular 1 cm2
ROI was placed on skeletal muscle and the Hounsﬁeld unit (HU)
standard deviation recorded to provide a measure of image noise.
CNR was calculated by dividing tumour enhancement (tumour peak
enhancement – baseline density) by the muscle ROI standard deviation.
2.5. Statistical analysis
The mean and standard deviation for each pCT parameter, image
noise and CNR were calculated for the diﬀerent ASIR percentages
(0–100%). Within-patient coeﬃcients of variation (CV) were calculated
for each parameter across the diﬀerent ASIR percentages (standard
deviation divided by mean), and expressed as a percentage value.
Repeated measures analysis of variance (rANOVA) of pCT parameters
was performed, using Greenhouse-Geisser (GG) correction when appro-
priate based on Mauchly’s test of sphericity, and followed by post hoc
testing using the Bonferroni method. Spearman rank order correlation
was performed to assess the associations of image noise and CNR with
ASIR percentage. Statistical signiﬁcance was assigned at the 5% level.
Statistical analysis was performed using IBM SPSS Statistics, Version 22
(IBM Corporation, New York, USA).
2.6. Sample size justiﬁcation
Retrospective power analysis under the guidance of a statistician
(GPower 3.1) showed that, with a 5% signiﬁcance level and 90% power,
13 subjects would be required to be able to detect a diﬀerence of 7 units
between two sets of parameter measurements (based on BF values),
equivalent to a clinically signiﬁcant 10% variation. Our actual sample
size of 32 meets these criteria with ample margins.
E-mail addresses: davide.prezzi@kcl.ac.uk, davide1756@icloud.com (D. Prezzi).
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Fig. 1. Axial perfusion CT image reconstructed with 0% (A), 60% (B) and 100% ASIR (C). Parametric blood ﬂow colour map (D).
Table 1
Mean ± SD for image noise and contrast to noise ratios for each ASIR percentage and the relative change between 0% and 100% ASIR are shown. Data are means ± standard
deviations, with ranges in parentheses.
Image quality ASIR percentage Relative change (%)
0% 20% 40% 60% 80% 100%
Noise 27.06 ± 4.57
(15.32–38.00)
28.24 ± 4.75
(15.32–38.71)
24.37 ± 4.32
(13.83–32.42)
22.40 ± 4.45
(11.23–33.74)
19.64 ± 3.72
(10.34–26.04)
18.16 ± 4.41
(10.08–28.01)
−32.8%
Contrast to noise 1.22 ± 1.08
(0.18–4.59)
1.20 ± 1.12
(0.16–4.92)
1.36 ± 1.28
(0.10–5.73)
1.53 ± 1.48
(0.21–6.73)
1.73 ± 1.69
(0.22–7.90)
1.96 ± 1.92
(0.21–9.23)
+60.7%
Fig. 2. Box and whisker plots of perfusion CT parameters across increasing ASIR levels. Solid line in box represents median value, upper and lower bars represent ﬁrst and third quartiles,
whiskers represent 95% conﬁdence intervals. P values of repeated measures ANOVA (with or without GG correction) are reported.
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3. Results
3.1. Image quality
Mean image noise (± standard deviation) decreased with increasing
ASIR percentages, changing from 27.06 ± 4.57 (range, 15.32-38.00) at
0% ASIR to 18.16 ± 4.41 (range, 10.08-28.01) at 100% ASIR, a relative
decrease of 32.8%. Mean tumour enhancement remained relatively stable
across ASIR levels, ranging on average between 33.01 ± 4.94 HU and
35.59 ± 8.47 HU (a relative change of 7.8%). Consequently, mean CNR
increased from 1.22 ± 1.08 (range, 0.18–4.59) to 1.96 ± 1.92 (range,
0.21–9.23), a relative increase of 60.7% (Table 1, Fig. 2). As expected,
there was a strong negative rank correlation between image noise and
ASIR level (r=−0.639; P < 0.001); a weak positive rank correlation
was found between CNR and ASIR level(r = 0.206; P=0.004).
3.2. Perfusion CT parameters
Mean BF, BV, MTT, PS and coeﬃcients of variation across increas-
ing ASIR percentages are summarised in Table 2 and Fig. 3. Mean
parameter values diﬀered by less than 1.8%, 2.9%, 2.5% and 2.6% for
BF, BV, MTT and PS respectively across the diﬀerent ASIR percentages.
Coeﬃcients of variation ranged between 3.3% and 7.9% for each of the
parameters. Repeated measures ANOVA showed that mean BF, BV and
PS measurements did not diﬀer substantially, with P values of 0.85,
0.62 and 0.81 respectively. Mean MTT measurements yielded a P value
of 0.02; post hoc tests using the Bonferroni correction, however,
revealed no signiﬁcant diﬀerence between pairs of ASIR levels (P
values = 0.23 to 1.00).
4. Discussion
In recent years there has been a step change in CT practice. The
emphasis on dose reduction has led to the widespread implementation
of hybrid iterative reconstruction techniques by all the major CT
manufacturers, in order to improve or maintain image quality with
low dose acquisitions. These hybrid algorithms combine ﬁltered back
projection data with iterative reconstruction methods. The potential
impact of iterative reconstruction on quantitative perfusion CT techni-
ques has not been explored for body tumours but is clearly relevant to
oncologic imaging.
In this study we showed that ASIR does not alter the tumour pCT
parameters BF, BV and PS substantially, with repeated measurements
ANOVA P values greater than 0.6; MTT diﬀered signiﬁcantly between
ASIR levels on ANOVA, though not so on post hoc pairwise compar-
isons; within-subject coeﬃcients of variation for all parameters were
smaller than 10%.
Image noise and CNR improved with increasing levels of ASIR at a
reduced peak kilovoltage of 100 kV, strengthening the case for the
implementation of low dose CT perfusion protocols within the con-
straints of an adequate CNR for quantitation.
Contrast enhancement within tumours, typically higher and more
heterogeneous than in normal solid organs, altered by less than 8%
across the diﬀerent ASIR percentages.
In general terms, the ﬁrst stage of iterative reconstruction produces
artiﬁcial raw data from the forward projection of a volumetric estimate
taken from either an empty image or a FBP reconstruction. Modelling of
the volumetric estimate is then undertaken and the many possible path
lengths, including the diﬀerent angles and orientations, at which the x-
ray photons could pass through the object are calculated; this way the
estimate mimics a more realistic pathway in which the x-ray photons
Table 2
Tumour perfusion CT measurements for each ASIR percentage, P values for repeated measures ANOVA and coeﬃcients of variation (CV) are shown. Data are means ± standard
deviations, with ranges in parentheses.
Perfusion CT parameter ASIR percentage P- value CV
(%)
0% 20% 40% 60% 80% 100%
Blood ﬂow (mL/min/100 g) 68.08 ± 20.31
(42.17–118.55)
67.75 ± 20.38
(41.31–114.99)
67.51 ± 20.62
(41.18–114.69)
68.13 ± 21.11
(40.68–126.09)
67.18 ± 20.10
(41.95–120.48)
66.93 ± 19.39
(40.80–112.45)
0.85 4.9 ± 3.4
Blood volume (mL/100 g) 7.09 ± 1.99
(4.17–11.35)
7.01 ± 1.99
(3.88–11.18)
7.03 ± 1.97
(3.71–12.05)
7.15 ± 1.96
(3.84–11.11)
7.10 ± 1.95
(4.09–10.92)
7.12 ± 2.03
(3.90–11.62)
0.62 4.2 ± 3.0
Mean transit time (sec) 7.54 ± 1.15
(4.70–9.91)
7.60 ± 1.29
(4.83–9.87)
7.62 ± 1.20
(4.84–10.03)
7.74 ± 1.24
(4.74–9.96)
7.74 ± 1.21
(4.78–9.88)
7.78 ± 1.29
(4.73–10.01)
0.02 3.3 ± 2.3
Permeability surface area product (mL/
min/100 g)
32.51 ± 7.65
(18.54–52.47)
32.20 ± 8.90
(18.00–52.82)
32.03 ± 8.84
(18.73–53.87)
32.08 ± 8.21
(19.49–51.32)
32.82 ± 9.17
(15.78–53.70)
32.76 ± 9.95
(12.99–59.52)
0.81 7.9 ± 3.6
Fig. 3. Box and whisker plots of image noise and CNR across increasing ASIR levels. Solid line in box represents median value, upper and lower bars represent ﬁrst and third quartiles,
whiskers represent 95% conﬁdence intervals.
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travel through the object to the detector; furthermore, instead of
placing the initial location of the x-ray photons over a single point,
like in FBP, it is placed over a small area. This artiﬁcial projection is
then compared to the actual measurement to construct an updated
image. Modiﬁcation of this updated image is repeated a number of
times until very little diﬀerences are present between the artiﬁcial
projection and real measurement. In the last stage, the updated image is
back projected onto the volumetric estimate. A phantom study compar-
ing two ﬁrst generation hybrid iterative reconstruction methods, ASIR
and iDose, has shown they provide similar beneﬁts, mainly acting on
image noise reduction [22].
Our results are in line with previous studies that have assessed the
eﬀect of commercially implemented iterative reconstruction techniques
within normal organs. Studies have shown that iDose and AIDR did not
substantially aﬀect quantitative perfusion CT parameters in normal
brain tissue [23,24], normal liver [25] and normal pancreas [26],
allowing dose reductions ranging between 20% and 56%. These hybrid
algorithms are diﬀerent to ASIR but have a similar aim of reducing
noise. iDose implemented by Philips applies an optimal anatomical
model in the image domain to iteratively eliminate the quantum image
noise and attempts to maintain the appearance of a ‘full dose FBP image
[27]; in adaptive iterative dose reduction, AIDR implemented by
Toshiba, statistical and scanner based models combined with projection
noise estimation are applied to FBP reconstructions and followed by an
iterative technique for optimisation [28].
The reported coeﬃcients of variation for CT Perfusion parameters
(3.3%–7.9%) are well within those previously reported for intra- and
inter-observer variation, supporting their clinical acceptability; for
example, a previous quantitative perfusion CT study in primary color-
ectal cancer reported mean intra-observer CV, based on same-study
repeated measurements, ranging between 6.2% (PS) and 27.9% (BV)
[28].
ASIR levels of 30–50% have been shown to provide acceptable
image noise and diagnostic conﬁdence in abdominal CT without a
substantial change in image appearance [18]: these levels have been
typically adopted in clinical practice for viewing purposes. Published
phantom- and patient-based CT perfusion image quality assessments,
for a reconstructed slice thickness of 5 mm in the pelvis, have shown
typical peak CNR values greater than 1.5 at 100 kV [29]. In our study, a
CNR greater than 1.5 was achieved with ASIR levels of 60% and above:
with the aim of striking a balance between achieving adequate CNR and
avoiding major changes in image appearance, typical of pure ASIR
algorithms, 60% will be our favored and recommended ASIR level for
tumour CT perfusion analysis below 100 kV in future studies, particu-
larly for tumours located in the pelvis, representing 27 out of 32
tumours in the current cohort (including rectum, sigmoid and cecum).
A reduced peak kilovoltage of 100 kV was adopted instead of the
“standard” 120 kV previously used for quantitative perfusion analysis
of colorectal tumours [30–32], aiming to strike a balance between dose
reduction and clinically acceptable image quality in a typical patient
cohort from the United Kingdom.
The current study has a few limitations. We only assessed the eﬀect
of ASIR on image quality and pCT quantitation at ﬁxed kV and mA
levels, having to adhere to a ﬁxed imaging protocol as part of a
prospective multicentric study; ethical issues would have to be con-
sidered with repeated acquisitions at multiple kV or mA levels in the
same patient. The patient cohort size (n = 32), albeit relatively small,
has been shown to have>99.9% power, with a 5% signiﬁcance level,
to show a diﬀerence of 7 units or more between two sets of parameter
measurements, equivalent to the clinically acceptable 10% parameter
variation (based on BF values).
In summary we found that ASIR improves image noise and contrast-
to-noise ratio and does not alter pCT tumour parameters substantially at
a reduced peak kilovoltage of 100 kV. These supportive data strengthen
the case for implementing lower dose pCT protocols in future clinical
practice, within the constraints of an adequate CNR for quantiﬁcation.
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